IFF (IFF) Appoints Frank Clyburn as CEO and Director
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/2/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
IFF Appoints Frank Clyburn as Chief Executive Officer and Board Director; Separates Chairman and Chief Executive Officer Roles
January 20, 2022 6:50 AM ESTNEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board of Directors, effective February 14, 2022.
Mr. Clyburn joins IFF from Merck & Co. (Merck), where he currently serves as Executive Vice President and President of Human Health and today has full P&L responsibility for nearly 90% of Mercks $48 billion business. He brings extensive experience leading complex global businesses and executing with exceptional operating discipline. Mr. Clyburn has an in-depth... More
